<html>
<head>
	<title>nby20180117_s8.htm</title>

	<!-- Created by RDG HTML Converter v1.1.0.0 1/17/2018 6:54:10 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no"/>
</head>
<body style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-right: 10px; margin-left: 10px; cursor: auto;">
<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 50%;">As filed with the Securities and Exchange Commission on January 19, 2018.<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</font></td>
			<td style="width: 50%; text-align: right;"><font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">Registration No. 333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></td>
		</tr>

</table>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>&nbsp;</b></p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>&nbsp;</b></p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>UNITED STATES</b></p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Washington, D.C. 20549</p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>FORM S-8</b></p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">REGISTRATION STATEMENT</p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">UNDER</p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">THE SECURITIES ACT OF 1933</p>

<p style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>NovaBay Pharmaceuticals, Inc.</b></p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">(Exact name of registrant as specified in its charter)</p>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 33.3%; vertical-align: top;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Delaware</b></p>
			</td>
			<td style="width: 33.3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 34.5%; vertical-align: top;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>68-0454536</b></p>
			</td>
		</tr>
		<tr>
			<td style="width: 33.3%; vertical-align: top;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">(State or other jurisdiction of</p>

			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">incorporation or organization)</p>
			</td>
			<td style="width: 33.3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 34.5%; vertical-align: top;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">(I.R.S. Employer Identification No.)</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>2000 Powell Street, Suite 1150, Emeryville, CA 94608<br>
<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">(510) 899-8800</font></b><br>
<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">(Address, including zip code, of Principal Executive Offices)</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>2017 Omnibus Incentive Plan</b><br>
<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">(Full title of the plan)</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Mark Sieczkarek<br>
<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">Chief Executive Officer and Chairman of the Board of Directors<br>
2000 Powell Street, Suite 1150<br>
Emeryville, CA 94608<br>
(510) 899-8800</font></b><br>
<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">(Name, address, and telephone number, including area code, of agent for service)</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Copies to:<br>
<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Abby E. Brown, Esq.</b></font></p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Squire Patton Boggs (US) LLP</b><br>
<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>2550 M Street, Northwest</b></font></p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Washington, DC 20037<br>
<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">(202) 457-6000</font></b></p>

<p style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: justify; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company,&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</p>

<p style="margin: 0pt; text-align: justify; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 65%; padding-left: 36pt;">Large accelerated filer <font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&#9744;</font><font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;&nbsp;&nbsp;</font></td>
			<td style="width: 35%;"><font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">Accelerated filer </font><font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&#9744;</font></td>
		</tr>
		<tr>
			<td style="width: 65%; padding-left: 36pt;">Non-accelerated filer <font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&#9744; (Do not check if a smaller reporting company) </font></td>
			<td style="width: 35%;"><font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">Smaller reporting company </font><font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&#9746;</font></td>
		</tr>
		<tr>
			<td style="width: 65%;">&nbsp;</td>
			<td style="width: 35%;"><font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">Emerging growth company &#9744;</font></td>
		</tr>

</table>

<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&#9744;</font></p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-right: 0pt; margin-left: 0pt;">
<div id="PGNUM" style="width: 100%; text-align: center;">&nbsp;</div>

<hr style="border: currentColor; border-image: none; width: 100%; height: 2px; color: rgb(0, 0, 0); page-break-after: always; background-color: rgb(0, 0, 0);">
<div id="PGHDR" style="width: 100%; text-align: left;">&nbsp;</div>
</div>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>CALCULATION OF REGISTRATION FEE </b></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt; border-collapse: collapse;">

		<tr style="border-top-color: rgb(0, 0, 0); border-top-width: 3px; border-top-style: double;">
			<td style="width: 37.9%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Title of Securities to be Registered</b></p>
			</td>
			<td style="width: 14.8%; vertical-align: bottom; border-right-color: rgb(0, 0, 0); border-bottom-color: rgb(0, 0, 0); border-left-color: rgb(0, 0, 0); border-right-width: 1px; border-bottom-width: 1px; border-left-width: 1px; border-right-style: solid; border-bottom-style: solid; border-left-style: solid;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Amount to be registered</b><font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><sup>(1)</sup></font></p>
			</td>
			<td style="width: 16.6%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Proposed </b></p>

			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>maximum </b></p>

			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>offering price </b></p>

			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>per share</b><font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><sup>(2)</sup></font></p>
			</td>
			<td style="width: 15.5%; vertical-align: bottom; border-right-color: rgb(0, 0, 0); border-bottom-color: rgb(0, 0, 0); border-left-color: rgb(0, 0, 0); border-right-width: 1px; border-bottom-width: 1px; border-left-width: 1px; border-right-style: solid; border-bottom-style: solid; border-left-style: solid;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Proposed</b></p>

			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>maximum </b></p>

			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>aggregate </b></p>

			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>offering </b></p>

			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>price</b><font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><sup>(2)</sup></font></p>
			</td>
			<td style="width: 16.3%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Amount of</b></p>

			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>registration fee</b><font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><sup>(2)</sup></font></p>
			</td>
		</tr>
		<tr style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">
			<td style="width: 37.9%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Common Stock, $0.01 par value per share</p>
			</td>
			<td style="width: 14.8%; vertical-align: top; border-right-color: rgb(0, 0, 0); border-bottom-color: rgb(0, 0, 0); border-left-color: rgb(0, 0, 0); border-right-width: 1px; border-bottom-width: 1px; border-left-width: 1px; border-right-style: solid; border-bottom-style: solid; border-left-style: solid;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">615,392 shares</p>
			</td>
			<td style="width: 16.6%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">$<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">3.60</font></p>
			</td>
			<td style="width: 15.5%; vertical-align: top; border-right-color: rgb(0, 0, 0); border-bottom-color: rgb(0, 0, 0); border-left-color: rgb(0, 0, 0); border-right-width: 1px; border-bottom-width: 3px; border-left-width: 1px; border-right-style: solid; border-bottom-style: double; border-left-style: solid;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">$<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">2,215,411.20</font></p>
			</td>
			<td style="width: 16.3%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">$<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">275.82</font></p>
			</td>
		</tr>
		<tr>
			<td colspan="5" style="width: 101.1%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">(1)&nbsp;&nbsp;&nbsp;&nbsp; <font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">This represents an increase in the number of shares of Common Stock of the registrant reserved for issuance under the NovaBay Pharmaceuticals, Inc. 2017 Omnibus Incentive Plan,<b>&nbsp;</b>pursuant to an evergreen provision contained in Section 4(a) therein. Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), this Registration Statement also covers any additional securities that may from time to time be offered or issued resulting from any stock splits, stock dividends, recapitalizations or other similar transactions.</font></p>

			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">(2)&nbsp;&nbsp;&nbsp;&nbsp; <font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">This calculation is made solely for the purpose of determining the registration fee pursuant to the provisions of Rule 457(c) and (h) under the Securities Act, based on the average of the high and low sales prices of the Registrant&rsquo;s Common Stock on January 17, 2018, as reported by NYSE American LLC. </font></p>

			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: center; text-transform: uppercase; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>EXPLANATORY NOTE</b></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: justify; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">This Registration Statement on Form S-8 registers a total of 615,392 shares of Common Stock, par value $0.01 per share, of NovaBay Pharmaceuticals, Inc., a Delaware corporation (the &ldquo;Registrant&rdquo; or the &ldquo;Company&rdquo;), for issuance under the NovaBay Pharmaceuticals, Inc. 2017 Omnibus Incentive Plan (the &ldquo;Plan&rdquo;). The number of shares of Common Stock available for issuance under the shareholder-approved Plan was subject to an automatic annual increase on the first day of each of the Company<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&rsquo;s fiscal years beginning on January 1, 2018 and ending on January 1, 2027 by an amount equal to (i)&nbsp;four percent (4%)&nbsp;of the number of shares of Common Stock outstanding on the last day of the immediately preceding fiscal year or (ii)&nbsp;such lesser number of shares of Common Stock as determined by the Board of Directors (the &ldquo;Board&rdquo;).&nbsp; For 2018, the Board authorized an increase of 615,392 shares of the Registrant&rsquo;s Common Stock under the Plan, consisting of the full four percent (4%) increase allowed pursuant to the Plan&rsquo;s evergreen provision. These shares are in addition to the 2,318,486 shares of Common Stock registered on the Company&rsquo;s Form S-8 filed on June 2, 2017 (File No. 333-218469). Since the Plan provides that the annual increase in the aggregate number of shares that may be issued pursuant to the Plan&rsquo;s evergreen provision begins for fiscal years commencing January 1, 2018, this Registration Statement accounts for the first share increase under the evergreen provision. </font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: justify; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The contents of the prior Registration Statement on Form S-8 filed with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) on June 2, 2017 (File No. 333-218469), is incorporated herein by reference and made part of this Registration Statement.</p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: justify; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">This Registration Statement relates to securities of the same class as those to which the prior Registration Statement, listed directly above, relates, and is submitted in accordance with General Instruction E to Form S-8 regarding Registration of Additional Securities.</p>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-right: 0pt; margin-left: 0pt;">
<div id="PGNUM" style="width: 100%; text-align: center;">&nbsp;</div>

<hr style="border: currentColor; border-image: none; width: 100%; height: 2px; color: rgb(0, 0, 0); page-break-after: always; background-color: rgb(0, 0, 0);">
<div id="PGHDR" style="width: 100%; text-align: left;">&nbsp;</div>
</div>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: center; text-transform: uppercase; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>PART</b><font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><b> II</b></font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: center; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</b></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Item 3. <font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;&nbsp;Incorporation of Documents by Reference.</font></b></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: justify; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">The following documents filed by the Company with the Commission are incorporated by reference into this Registration Statement:</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">1.</p>
			</td>
			<td>
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">The Company<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2016, as filed on March 23, 2017. </font></p>
			</td>
		</tr>

</table>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">2.</p>
			</td>
			<td>
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">The Company<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&rsquo;s Quarterly Reports on Forms 10-Q for the quarters ended March 31, 2017 as filed on May 11, 2017, June 30, 2017 as filed on August 10, 2017, and September 30, 2017 as filed on November 14, 2017.</font></p>
			</td>
		</tr>

</table>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">3.</p>
			</td>
			<td>
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">The Company<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&rsquo;s Current Reports on Form 8-K filed on May 19, 2017, June 6, 2017, July 10, 2017, September 20, 2017, November 21, 2017, November 28, 2017, December 12, 2017, December 20, 2017, and December 22, 2017. </font></p>
			</td>
		</tr>

</table>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">4.</p>
			</td>
			<td>
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">The description of the Company<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&rsquo;s Common Stock which is contained in the Company&rsquo;s Current Report on Form 8<b>-</b>K filed on June 29, 2010.</font></p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: justify; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">All reports and other documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part of this Registration Statement from the date of the filing of such reports and documents. Any such information so modified or superseded shall not be deemed, except as so modified or superseded, to constitute part of this Registration Statement.</p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: justify; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Notwithstanding the foregoing, we are not incorporating by reference information furnished under Items 2.02 and 7.01 of any Current Report on Form 8-K, including the related exhibits, nor any other document or information deemed to have been furnished and not filed in accordance with Commission rules.</p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Item 4. <font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;&nbsp;Description of Securities. </font></b></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Not applicable.</p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Item 5.<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;&nbsp; Interests of Named Experts and Counsel.</font></b></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">The validity of the issuance of the shares of Common Stock registered under this Registration Statement has been passed upon for the Registrant by Squire Patton Boggs (US) LLP.</p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Item 6.<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;&nbsp; Indemnification of Directors and Officers.</font></b></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Incorporated by reference to Item 6 in the Company<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&rsquo;s Registration Statement on Form S-8, filed with the Commission on June 2, 2017.</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Item 7.<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;&nbsp;&nbsp;Exemption from Registration Claimed.</font></b></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Not applicable.</p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Item 8.<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;&nbsp;&nbsp;Exhibits.</font></b></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 8%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Exhibit No.</b></p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Description of Document</b></p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">4.1<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><sup>(1)</sup></font></p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">Amended and Restated Certificate of Incorporation of NovaBay Pharmaceuticals, Inc.</p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">4.2<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><sup>(2)</sup></font></p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">Certificate of Amendment of Amended and Restated Certificate of Incorporation of NovaBay Pharmaceuticals, Inc.</p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">4.3<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><sup>(3)</sup></font></p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">Certificate of Amendment of Amended and Restated Certificate of Incorporation of NovaBay Pharmaceuticals, Inc.</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-right: 0pt; margin-left: 0pt;">
<div id="PGNUM" style="width: 100%; text-align: center;">&nbsp;</div>

<hr style="border: currentColor; border-image: none; width: 100%; height: 2px; color: rgb(0, 0, 0); page-break-after: always; background-color: rgb(0, 0, 0);">
<div id="PGHDR" style="width: 100%; text-align: left;">&nbsp;</div>
</div>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">4.4<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><sup>(4)</sup></font></p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">Certificate of Amendment of Amended and Restated Certificate of Incorporation of NovaBay Pharmaceuticals, Inc.</p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">4.5<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><sup>(5)</sup></font></p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">Bylaws of NovaBay Pharmaceuticals, Inc.</p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">5.1</p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">Opinion of Squire Patton Boggs (US) LLP</p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">23.1</p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">Consent of OUM &amp; Co. LLP</p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">23.2</p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">Consent of Squire Patton Boggs (US) LLP (included in Exhibit 5.1)</p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">24.1</p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">Power of Attorney to file future amendments (set forth on the signature page of this Registration Statement)</p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">99.1<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><sup>(6)</sup></font></p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">NovaBay Pharmaceuticals, Inc. 2017 Omnibus Incentive Plan</p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">99.2<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><sup>(7)</sup></font></p>

			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">Forms of agreements for use under the NovaBay Pharmaceuticals, Inc. 2017 Omnibus Incentive Plan</p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 36pt; vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">(1)</p>
			</td>
			<td style="vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">Incorporated by reference to Exhibit 3.1 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on June 29, 2010.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 36pt; vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">(2)</p>
			</td>
			<td style="vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">Incorporated by reference to Exhibit 3.1 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on June 4, 2014.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 36pt; vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">(3)</p>
			</td>
			<td style="vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">Incorporated by reference to Exhibit 3.1 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on October 2, 2015.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 36pt; vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">(4)</p>
			</td>
			<td style="vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">Incorporated by reference to Exhibit 3.1 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on December 21, 2015.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 36pt; vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">(5)</p>
			</td>
			<td style="vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">Incorporated by reference to Exhibit 3.2 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on June 29, 2010.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 36pt; vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">(6)</p>
			</td>
			<td style="vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">Incorporated by reference to Exhibit 99.1 to the Company<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&rsquo;s Registration Statement on Form S-8 (File No. 333-218469), as filed with the Commission on June 2, 2017.</font></p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 36pt; vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">(7)</p>
			</td>
			<td style="vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">Incorporated by reference to Exhibit 99.2 to the Company<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&rsquo;s Registration Statement on Form S-8 (File No. 333-218469), as filed with the Commission on June 2, 2017. </font></p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Item 9.<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;&nbsp;&nbsp;Undertakings.</font></b></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">Incorporated by reference to Item 9 in the Company<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&rsquo;s Registration Statement on Form S-8, filed with the Commission on June 2, 2017. </font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><sup>&nbsp;</sup></p>

<div id="PGBK" style="width: 100%; margin-right: 0pt; margin-left: 0pt;">
<div id="PGNUM" style="width: 100%; text-align: center;">&nbsp;</div>

<hr style="border: currentColor; border-image: none; width: 100%; height: 2px; color: rgb(0, 0, 0); page-break-after: always; background-color: rgb(0, 0, 0);">
<div id="PGHDR" style="width: 100%; text-align: left;">&nbsp;</div>
</div>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>&nbsp;</b></p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>SIGNATURES</b></p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: justify; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Emeryville, State of California on January 19, 2018.</p>

<p style="margin: 0pt; text-align: left; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>&nbsp;</b></p>

<p style="margin: 0pt; text-align: left; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>&nbsp;</b></p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: Times New Roman; font-size: 10pt;">

		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td valign="top" width="3%">&nbsp;</td>
			<td valign="top" width="35%"><b>NOVABAY PHARMACEUTICALS, INC</b><font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>.</b></font></td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: Times New Roman; font-size: 10pt;">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: Times New Roman; font-size: 10pt;">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: Times New Roman; font-size: 10pt;">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: Times New Roman; font-size: 10pt;">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: Times New Roman; font-size: 10pt;">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: Times New Roman; font-size: 10pt;">&nbsp;</font></p>
			</td>
			<td align="left" nowrap="nowrap" valign="bottom" width="35%">
			<p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: Times New Roman; font-size: 10pt;">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: Times New Roman; font-size: 10pt;">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td align="left" style="text-align: left;" valign="top" width="50%">
			<p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: Times New Roman; font-size: 10pt;">&nbsp;</font></p>
			</td>
			<td style="text-align: left;" valign="top" width="3%">
			<p style="margin-top: 0px; margin-bottom: 0px;">&nbsp;</p>
			</td>
			<td align="left" nowrap="nowrap" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;" valign="top" width="35%">
			<p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: Times New Roman; font-size: 10pt;">/s/&nbsp;</font>Mark M. Sieczkarek</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: Times New Roman; font-size: 10pt;">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: Times New Roman; font-size: 10pt;">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: Times New Roman; font-size: 10pt;">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0px; margin-bottom: 0px;">Mark M. Sieczkarek</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: Times New Roman; font-size: 10pt;">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: Times New Roman; font-size: 10pt;">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: Times New Roman; font-size: 10pt;">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">Chief Executive Officer and Chairman of the Board</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: Times New Roman; font-size: 10pt;">&nbsp;</font></p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-right: 0pt; margin-left: 0pt;">
<div id="PGNUM" style="width: 100%; text-align: center;">&nbsp;</div>

<hr style="border: currentColor; border-image: none; width: 100%; height: 2px; color: rgb(0, 0, 0); page-break-after: always; background-color: rgb(0, 0, 0);">
<div id="PGHDR" style="width: 100%; text-align: left;">&nbsp;</div>
</div>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b><a id="poa" name="poa"></a>POWER OF ATTORNEY</b></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: justify; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">KNOW ALL PERSONS BY THESE PRESENTS that each of the undersigned officers and directors does hereby constitute and appoint Mark M. Sieczkarek, John J. McGovern and Justin Hall, and each of them, or their substitute or substitutes, as his or her true and lawful attorneys-in-fact and agents, with full power and authority to do any and all acts and things and to execute and file or cause to be filed any and all instruments, documents or exhibits which said attorneys and agents, or any one of them, determine may be necessary or advisable or required to enable said corporation to comply with the Securities Act of 1933, as amended, and any rules or regulations or requirements of the Securities and Exchange Commission in connection with this Registration Statement. Without limiting the generality of the foregoing power and authority, the powers granted include the power and authority to sign the names of the undersigned officers and directors in the capacities indicated below to this Registration Statement, to any and all amendments, both pre-effective and post-effective, and supplements to this Registration Statement and to any and all instruments, documents or exhibits filed as part of, or in conjunction with, this Registration Statement or amendments or supplements thereof, with the powers of substitution and revocation, and each of the undersigned hereby ratifies and confirms all that said attorneys and agents, or any one of them, or their substitute or substitutes, shall lawfully do or cause to be done by virtue hereof. In witness whereof, each of the undersigned has executed this Power of Attorney as of the dates indicated below.</p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: justify; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated. This document may be executed by the signatories hereto on any number of counterparts, all of which shall constitute one and the same instrument.</p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Signature</b></p>
			</td>
			<td style="width: 2.8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Title</b></p>
			</td>
			<td style="width: 2.8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Date</b></p>
			</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">/s/ Mark M. Sieczkarek</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Chief Executive Officer and Chairman of the Board</p>

			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><i>(principal executive officer)</i></p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">January 19, 2018</p>
			</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Mark M. Sieczkarek</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">/s/ John J. McGovern</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Chief Financial Officer and Treasurer</p>

			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><i>(principal financial and accounting officer)</i></font></p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">January 19, 2018</p>
			</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">John J. McGovern</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">/s/ Paul E. Freiman</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Director</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">January 19, 2018</p>
			</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Paul E. Freiman</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">/s/ Xinzhou (Paul) Li</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Director</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">January 19, 2018</p>
			</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Xinzhou (Paul) Li</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">/s/ Xiaoyan (Henry) Liu</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Director</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">January 19, 2018</p>
			</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Xiaoyan (Henry) Liu</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">/s/ Yonghao (Carl) Ma</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Director</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">January 19, 2018</p>
			</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Yonghao (Carl) Ma</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">/s/ Gail J. Maderis</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Director</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">January 19, 2018</p>
			</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Gail J. Maderis</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">/s/ <font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">Mijia (Bob) Wu</font></p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Director</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">January 19, 2018</p>
			</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Mijia (Bob) Wu</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">/s/ Todd Zavodnick</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Director</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">
			<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">January 19, 2018</p>
			</td>
		</tr>
		<tr>
			<td style="width: 33.4%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Todd Zavodnick</p>
			</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 38%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 2.8%; vertical-align: bottom;">&nbsp;</td>
			<td style="width: 23.9%; vertical-align: bottom;">&nbsp;</td>
		</tr>

</table>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>&nbsp;</b></p>

<div id="PGBK" style="width: 100%; margin-right: 0pt; margin-left: 0pt;">
<div id="PGNUM" style="width: 100%; text-align: center;">&nbsp;</div>

<hr style="border: currentColor; border-image: none; width: 100%; height: 2px; color: rgb(0, 0, 0); page-break-after: always; background-color: rgb(0, 0, 0);">
<div id="PGHDR" style="width: 100%; text-align: left;">&nbsp;</div>
</div>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>EXHIBIT INDEX</b></p>

<p style="margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 8%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Exhibit No.</b></p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b>Description of Document</b></p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">4.1<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><sup>(1)</sup></font></p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774910002032/ex3-1.htm" style="-sec-extract: exhibit;">Amended and Restated Certificate of Incorporation of NovaBay Pharmaceuticals, Inc.</a></p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">4.2<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><sup>(2)</sup></font></p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774914010661/ex3-1.htm" style="-sec-extract: exhibit;">Certificate of Amendment of Amended and Restated Certificate of Incorporation of NovaBay Pharmaceuticals, Inc.</a></p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">4.3<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><sup>(3)</sup></font></p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774915017937/ex3-1.htm" style="-sec-extract: exhibit;">Certificate of Amendment of Amended and Restated Certificate of Incorporation of NovaBay Pharmaceuticals, Inc.</a></p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">4.4<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><sup>(4)</sup></font></p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774915022582/ex3-1.htm" style="-sec-extract: exhibit;">Certificate of Amendment of Amended and Restated Certificate of Incorporation of NovaBay Pharmaceuticals, Inc.</a></p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">4.5<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><sup>(5)</sup></font></p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774910002032/ex3-2.htm" style="-sec-extract: exhibit;">Bylaws of NovaBay Pharmaceuticals, Inc.</a></p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">5.1</p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><a href="ex_103165.htm" style="-sec-extract: exhibit;">Opinion of Squire Patton Boggs (US) LLP</a></p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">23.1</p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><a href="ex_103166.htm" style="-sec-extract: exhibit;">Consent of OUM &amp; Co. LLP</a></p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">23.2</p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><a href="ex_103165.htm" style="-sec-extract: exhibit;">Consent of Squire Patton Boggs (US) LLP (included in Exhibit 5.1)</a></p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">24.1</p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><a href="#poa" style="-sec-extract: exhibit;">Power of Attorney to file future amendments (set forth on the signature page of this Registration Statement)</a></p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">99.1<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><sup>(6)</sup></font></p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774917010557/ex99-1.htm" style="-sec-extract: exhibit;">NovaBay Pharmaceuticals, Inc. 2017 Omnibus Incentive Plan</a></p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">
			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">99.2<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><sup>(7)</sup></font></p>

			<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>
			</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774917010557/ex99-2.htm" style="-sec-extract: exhibit;">Forms of agreements for use under the NovaBay Pharmaceuticals, Inc. 2017 Omnibus Incentive Plan</a></p>
			</td>
		</tr>
		<tr>
			<td style="width: 8%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;">&nbsp;</td>
			<td style="width: 3%; vertical-align: top;">&nbsp;</td>
			<td style="width: 89%; vertical-align: top;">&nbsp;</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 36pt; vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">(1)</p>
			</td>
			<td style="vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">Incorporated by reference to Exhibit 3.1 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on June 29, 2010.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 36pt; vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">(2)</p>
			</td>
			<td style="vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">Incorporated by reference to Exhibit 3.1 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on June 4, 2014.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 36pt; vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">(3)</p>
			</td>
			<td style="vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">Incorporated by reference to Exhibit 3.1 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on October 2, 2015.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 36pt; vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">(4)</p>
			</td>
			<td style="vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">Incorporated by reference to Exhibit 3.1 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on December 21, 2015.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 36pt; vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">(5)</p>
			</td>
			<td style="vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">Incorporated by reference to Exhibit 3.2 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on June 29, 2010.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 36pt; vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">(6)</p>
			</td>
			<td style="vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">Incorporated by reference to Exhibit 99.1 to the Company<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&rsquo;s Registration Statement on Form S-8 (File No. 333-218469), as filed with the Commission on June 2, 2017.</font></p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman, Times, serif; font-size: 10pt;">

		<tr>
			<td style="width: 36pt; vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">(7)</p>
			</td>
			<td style="vertical-align: top;">
			<p style="text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt;">Incorporated by reference to Exhibit 99.2 to the Company<font style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&rsquo;s Registration Statement on Form S-8 (File No. 333-218469), as filed with the Commission on June 2, 2017. </font></p>
			</td>
		</tr>

</table>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>
</body>
</html>
[{"type": "S-8", "sequence": "1", "filename": "nby20180117_s8.htm", "description": "FORM S-8", "secsgml_size_bytes": 91257}]
{"company-data": {"conformed-name": "NovaBay Pharmaceuticals, Inc.", "cik": "0001389545", "assigned-sic": "2834", "irs-number": "680454536", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-222625", "film-number": "18537652"}, "business-address": {"street1": "2000 POWELL STREET, SUITE 1150", "city": "EMERYVILLE", "state": "CA", "zip": "94608", "phone": "(510) 899-8800"}, "mail-address": {"street1": "2000 POWELL STREET, SUITE 1150", "city": "EMERYVILLE", "state": "CA", "zip": "94608"}}
nby20180117_s8.htm
As filed with the Securities and Exchange Commission on January 19, 2018.
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
NovaBay Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
Delaware
68-0454536
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer Identification No.)
2000 Powell Street, Suite 1150, Emeryville, CA 94608
(510) 899-8800
(Address, including zip code, of Principal Executive Offices)
2017 Omnibus Incentive Plan
(Full title of the plan)
Mark Sieczkarek
Chief Executive Officer and Chairman of the Board of Directors
2000 Powell Street, Suite 1150
Emeryville, CA 94608
(510) 899-8800
(Name, address, and telephone number, including area code, of agent for service)
Copies to:
Abby E. Brown, Esq.
Squire Patton Boggs (US) LLP
2550 M Street, Northwest
Washington, DC 20037
(202) 457-6000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☐
Accelerated filer
☐
Non-accelerated filer
☐ (Do not check if a smaller reporting company)
Smaller reporting company
☒
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
☐
CALCULATION OF REGISTRATION FEE
Title of Securities to be Registered
Amount to be registered
(1)
Proposed
maximum
offering price
per share
(2)
Proposed
maximum
aggregate
offering
price
(2)
Amount of
registration fee
(2)
Common Stock, $0.01 par value per share
615,392 shares
$
3.60
$
2,215,411.20
$
275.82
(1)
This represents an increase in the number of shares of Common Stock of the registrant reserved for issuance under the NovaBay Pharmaceuticals, Inc. 2017 Omnibus Incentive Plan,
pursuant to an evergreen provision contained in Section 4(a) therein. Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers any additional securities that may from time to time be offered or issued resulting from any stock splits, stock dividends, recapitalizations or other similar transactions.
(2)
This calculation is made solely for the purpose of determining the registration fee pursuant to the provisions of Rule 457(c) and (h) under the Securities Act, based on the average of the high and low sales prices of the Registrant's Common Stock on January 17, 2018, as reported by NYSE American LLC.
EXPLANATORY NOTE
This Registration Statement on Form S-8 registers a total of 615,392 shares of Common Stock, par value $0.01 per share, of NovaBay Pharmaceuticals, Inc., a Delaware corporation (the "Registrant" or the "Company"), for issuance under the NovaBay Pharmaceuticals, Inc. 2017 Omnibus Incentive Plan (the "Plan"). The number of shares of Common Stock available for issuance under the shareholder-approved Plan was subject to an automatic annual increase on the first day of each of the Company
's fiscal years beginning on January 1, 2018 and ending on January 1, 2027 by an amount equal to (i) four percent (4%) of the number of shares of Common Stock outstanding on the last day of the immediately preceding fiscal year or (ii) such lesser number of shares of Common Stock as determined by the Board of Directors (the "Board").  For 2018, the Board authorized an increase of 615,392 shares of the Registrant's Common Stock under the Plan, consisting of the full four percent (4%) increase allowed pursuant to the Plan's evergreen provision. These shares are in addition to the 2,318,486 shares of Common Stock registered on the Company's Form S-8 filed on June 2, 2017 (File No. 333-218469). Since the Plan provides that the annual increase in the aggregate number of shares that may be issued pursuant to the Plan's evergreen provision begins for fiscal years commencing January 1, 2018, this Registration Statement accounts for the first share increase under the evergreen provision.
The contents of the prior Registration Statement on Form S-8 filed with the Securities and Exchange Commission (the "Commission") on June 2, 2017 (File No. 333-218469), is incorporated herein by reference and made part of this Registration Statement.
This Registration Statement relates to securities of the same class as those to which the prior Registration Statement, listed directly above, relates, and is submitted in accordance with General Instruction E to Form S-8 regarding Registration of Additional Securities.
PART
II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3.
Incorporation of Documents by Reference.
The following documents filed by the Company with the Commission are incorporated by reference into this Registration Statement:
1.
The Company
's Annual Report on Form 10-K for the year ended December 31, 2016, as filed on March 23, 2017.
2.
The Company
's Quarterly Reports on Forms 10-Q for the quarters ended March 31, 2017 as filed on May 11, 2017, June 30, 2017 as filed on August 10, 2017, and September 30, 2017 as filed on November 14, 2017.
3.
The Company
's Current Reports on Form 8-K filed on May 19, 2017, June 6, 2017, July 10, 2017, September 20, 2017, November 21, 2017, November 28, 2017, December 12, 2017, December 20, 2017, and December 22, 2017.
4.
The description of the Company
's Common Stock which is contained in the Company's Current Report on Form 8
-
K filed on June 29, 2010.
All reports and other documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part of this Registration Statement from the date of the filing of such reports and documents. Any such information so modified or superseded shall not be deemed, except as so modified or superseded, to constitute part of this Registration Statement.
Notwithstanding the foregoing, we are not incorporating by reference information furnished under Items 2.02 and 7.01 of any Current Report on Form 8-K, including the related exhibits, nor any other document or information deemed to have been furnished and not filed in accordance with Commission rules.
Item 4.
Description of Securities.
Not applicable.
Item 5.
Interests of Named Experts and Counsel.
The validity of the issuance of the shares of Common Stock registered under this Registration Statement has been passed upon for the Registrant by Squire Patton Boggs (US) LLP.
Item 6.
Indemnification of Directors and Officers.
Incorporated by reference to Item 6 in the Company
's Registration Statement on Form S-8, filed with the Commission on June 2, 2017.
Item 7.
Exemption from Registration Claimed.
Not applicable.
Item 8.
Exhibits.
Exhibit No.
Description of Document
4.1
(1)
Amended and Restated Certificate of Incorporation of NovaBay Pharmaceuticals, Inc.
4.2
(2)
Certificate of Amendment of Amended and Restated Certificate of Incorporation of NovaBay Pharmaceuticals, Inc.
4.3
(3)
Certificate of Amendment of Amended and Restated Certificate of Incorporation of NovaBay Pharmaceuticals, Inc.
4.4
(4)
Certificate of Amendment of Amended and Restated Certificate of Incorporation of NovaBay Pharmaceuticals, Inc.
4.5
(5)
Bylaws of NovaBay Pharmaceuticals, Inc.
5.1
Opinion of Squire Patton Boggs (US) LLP
23.1
Consent of OUM & Co. LLP
23.2
Consent of Squire Patton Boggs (US) LLP (included in Exhibit 5.1)
24.1
Power of Attorney to file future amendments (set forth on the signature page of this Registration Statement)
99.1
(6)
NovaBay Pharmaceuticals, Inc. 2017 Omnibus Incentive Plan
99.2
(7)
Forms of agreements for use under the NovaBay Pharmaceuticals, Inc. 2017 Omnibus Incentive Plan
(1)
Incorporated by reference to Exhibit 3.1 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on June 29, 2010.
(2)
Incorporated by reference to Exhibit 3.1 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on June 4, 2014.
(3)
Incorporated by reference to Exhibit 3.1 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on October 2, 2015.
(4)
Incorporated by reference to Exhibit 3.1 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on December 21, 2015.
(5)
Incorporated by reference to Exhibit 3.2 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on June 29, 2010.
(6)
Incorporated by reference to Exhibit 99.1 to the Company
's Registration Statement on Form S-8 (File No. 333-218469), as filed with the Commission on June 2, 2017.
(7)
Incorporated by reference to Exhibit 99.2 to the Company
's Registration Statement on Form S-8 (File No. 333-218469), as filed with the Commission on June 2, 2017.
Item 9.
Undertakings.
Incorporated by reference to Item 9 in the Company
's Registration Statement on Form S-8, filed with the Commission on June 2, 2017.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Emeryville, State of California on January 19, 2018.
NOVABAY PHARMACEUTICALS, INC
.
/s/
Mark M. Sieczkarek
Mark M. Sieczkarek
Chief Executive Officer and Chairman of the Board
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS that each of the undersigned officers and directors does hereby constitute and appoint Mark M. Sieczkarek, John J. McGovern and Justin Hall, and each of them, or their substitute or substitutes, as his or her true and lawful attorneys-in-fact and agents, with full power and authority to do any and all acts and things and to execute and file or cause to be filed any and all instruments, documents or exhibits which said attorneys and agents, or any one of them, determine may be necessary or advisable or required to enable said corporation to comply with the Securities Act of 1933, as amended, and any rules or regulations or requirements of the Securities and Exchange Commission in connection with this Registration Statement. Without limiting the generality of the foregoing power and authority, the powers granted include the power and authority to sign the names of the undersigned officers and directors in the capacities indicated below to this Registration Statement, to any and all amendments, both pre-effective and post-effective, and supplements to this Registration Statement and to any and all instruments, documents or exhibits filed as part of, or in conjunction with, this Registration Statement or amendments or supplements thereof, with the powers of substitution and revocation, and each of the undersigned hereby ratifies and confirms all that said attorneys and agents, or any one of them, or their substitute or substitutes, shall lawfully do or cause to be done by virtue hereof. In witness whereof, each of the undersigned has executed this Power of Attorney as of the dates indicated below.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated. This document may be executed by the signatories hereto on any number of counterparts, all of which shall constitute one and the same instrument.
Signature
Title
Date
/s/ Mark M. Sieczkarek
Chief Executive Officer and Chairman of the Board
(principal executive officer)
January 19, 2018
Mark M. Sieczkarek
/s/ John J. McGovern
Chief Financial Officer and Treasurer
(principal financial and accounting officer)
January 19, 2018
John J. McGovern
/s/ Paul E. Freiman
Director
January 19, 2018
Paul E. Freiman
/s/ Xinzhou (Paul) Li
Director
January 19, 2018
Xinzhou (Paul) Li
/s/ Xiaoyan (Henry) Liu
Director
January 19, 2018
Xiaoyan (Henry) Liu
/s/ Yonghao (Carl) Ma
Director
January 19, 2018
Yonghao (Carl) Ma
/s/ Gail J. Maderis
Director
January 19, 2018
Gail J. Maderis
/s/
Mijia (Bob) Wu
Director
January 19, 2018
Mijia (Bob) Wu
/s/ Todd Zavodnick
Director
January 19, 2018
Todd Zavodnick
EXHIBIT INDEX
Exhibit No.
Description of Document
4.1
(1)
Amended and Restated Certificate of Incorporation of NovaBay Pharmaceuticals, Inc.
4.2
(2)
Certificate of Amendment of Amended and Restated Certificate of Incorporation of NovaBay Pharmaceuticals, Inc.
4.3
(3)
Certificate of Amendment of Amended and Restated Certificate of Incorporation of NovaBay Pharmaceuticals, Inc.
4.4
(4)
Certificate of Amendment of Amended and Restated Certificate of Incorporation of NovaBay Pharmaceuticals, Inc.
4.5
(5)
Bylaws of NovaBay Pharmaceuticals, Inc.
5.1
Opinion of Squire Patton Boggs (US) LLP
23.1
Consent of OUM & Co. LLP
23.2
Consent of Squire Patton Boggs (US) LLP (included in Exhibit 5.1)
24.1
Power of Attorney to file future amendments (set forth on the signature page of this Registration Statement)
99.1
(6)
NovaBay Pharmaceuticals, Inc. 2017 Omnibus Incentive Plan
99.2
(7)
Forms of agreements for use under the NovaBay Pharmaceuticals, Inc. 2017 Omnibus Incentive Plan
(1)
Incorporated by reference to Exhibit 3.1 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on June 29, 2010.
(2)
Incorporated by reference to Exhibit 3.1 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on June 4, 2014.
(3)
Incorporated by reference to Exhibit 3.1 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on October 2, 2015.
(4)
Incorporated by reference to Exhibit 3.1 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on December 21, 2015.
(5)
Incorporated by reference to Exhibit 3.2 of the Company report on Current Form 8-K (File No. 001-33678), as filed with the Commission on June 29, 2010.
(6)
Incorporated by reference to Exhibit 99.1 to the Company
's Registration Statement on Form S-8 (File No. 333-218469), as filed with the Commission on June 2, 2017.
(7)
Incorporated by reference to Exhibit 99.2 to the Company
's Registration Statement on Form S-8 (File No. 333-218469), as filed with the Commission on June 2, 2017.